Denis Arsenault
completes objectives as Organigram board member
MONCTON, NB, March 29, 2018 /CNW/ – Organigram Holdings Inc.
(TSX VENTURE:OGI) (OTCQB:OGRMF) (the "Company" or
"Organigram"), a leading licensed producer of medical
marijuana based in Moncton, New
Brunswick, announced today that the Company has reluctantly
accepted the resignation of Denis
Arsenault following over three and a half years of dedicated
service on the Organigram Board of Directors.
Mr. Arsenault has been a driving force behind the development
and growth of Organigram and his dedication and commitment to the
Company has played a key role in building the foundation from which
the Company has grown. "It was four years ago this month when
I returned to my hometown to join Organigram. I am very proud
of what we have accomplished together, with employment numbers
expected to be above 270 full time jobs by the end of 2018, and a
recently announced international division" stated Arsenault.
"The decision to pass the torch and focus on other priorities was a
very easy and much anticipated one."
Mr. Arsenault will continue to provide strategic guidance to the
Company on an ad hoc basis.
Peter Amirault, an experienced
corporate participant and the current Lead Director, will move into
the role of Chairman going forward. Mr. Amirault has
extensive corporate experience as CEO of Creemore Springs Brewery
Ltd., President of Swiss Chalet North America and Senior
Vice-President of Molson Coors
Canada, as well as directorship experience. "During
his tenure with Organigram, Peter has demonstrated strong
leadership skills and excellent business acumen" stated
Arsenault. "I am certain that he will continue to steward the
Company going forward with a view to organizational
excellence".
Organigram's Chief Executive Officer, Greg Engel, commented, "on behalf of the entire
Organigram organization, we sincerely thank Denis for his
immeasurable contribution and strategic vision during his tenure at
Organigram - both as an officer and a director. We look
forward to his continued engagement as part of the Organigram
family."
About Organigram Holdings Inc.
Organigram Holdings Inc. is a TSX Venture Exchange listed
company whose wholly owned subsidiary, Organigram Inc., is a
licensed producer of medical marijuana in Canada. Organigram is focused on producing the
highest quality, condition specific medical marijuana for patients
in Canada. Organigram's facility
is located in Moncton, New
Brunswick and the Company is regulated by the Access to
Cannabis for Medical Purposes Regulations ("ACMPR").
Organigram has been ranked in the top ten Clean Technology
& Life Sciences Sector on the TSX Venture Exchange 50.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
This news release contains forward-looking information which
involves known and unknown risks, uncertainties and other factors
that may cause actual events to differ materially from current
expectations. Important factors - including the availability of
funds, consummation of definitive documentation, the results of
financing efforts, crop yields - that could cause actual results to
differ materially from the Company's expectations are disclosed in
the Company's documents filed from time to time on SEDAR (see
www.sedar.com). Readers are cautioned not to place undue reliance
on these forward-looking statements, which speak only as of the
date of this press release. The Company disclaims any intention or
obligation, except to the extent required by law, to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise.
For more information, visit www.Organigram.ca
SOURCE Organigram Holdings Inc.